Loading data for ATNM — first visit, this takes a few seconds.

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American: ATNM · Echtzeitkurs · USD

1.02

+0.02 (2.00%)

Zum Schluss: Sep 02, 2026, 8:00 PM

1.06

+6.00%

Nachbörslich: 7:30 PM

Preisalarm

Alert

Kurs, die wichtigsten Kennzahlen und die neuesten Nachrichten an einem Ort.

Keine Daten verfügbar

Geld	1.01
Marktkapitalisierung	31.4M
Umsatz (TTM)	35.1M
Nettogewinn (TTM)	11.3M
	0.02
	0.35
	2.86
	-1.9
KBV (TTM)	1.04
KUV (TTM)	0.89
Termin Quartalszahlen	n/a

Brief	1.02
Volumen	57,824
Ø Vol. (20D)	138,647
Eröffnung	1.00
Vortagesschluss	1.00
Tagesspanne	1.00 - 1.04
52-Wk Range	0.73 - 1.76
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über ATNM

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a CD33 targeting radiotherapeutic for patients with Relapsed/Refractory AML which is in to a Phase 2/3 Trial; and Iomab-ACT, to improve patient access to and outcomes with cellular therapies, such as CAR-T and gene therapies for no...

[Mehr lesen]

Branche Biotechnology

Sektor Healthcare

IPO Datum Dec 27, 2012

Mitarbeiter 27

Börse NYSE American

Tickersymbol ATNM

Website https://www.actiniumpharma.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Actinium Pharmaceuticals 90K, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -33.89 Mio, ein Rückgang von -11.39 %.

Finanzberichte

Gewinnüberraschung

Actinium Pharmaceuticals hat die Quartalszahlen am Aug 7, 2026 veröffentlicht:

Umsatz von $0 verfehlt die Erwartungen um $0, mit NaN% Wachstum im Jahresvergleich.
EPS von 0.89 übertrifft die Erwartungen um 1.09, mit 504.55% Wachstum im Jahresvergleich.

Warum der Kurs sich bewegte

Nachrichten

vor 8 Monaten · Zacks

Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year?

Here is how Actinium Pharmaceuticals (ATNM) and Collegium Pharmaceutical (COLL) have performed compared to their sector so far this year.

vor 9 Monaten · Zacks

Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year?

Here is how Alpha Cognition Inc. (ACOG) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.

vor 9 Monaten · Zacks

Is Alpha Cognition Inc. (ACOG) Stock Outpacing Its Medical Peers This Year?

Here is how Alpha Cognition Inc. (ACOG) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.

vor 9 Monaten · Associated Press Finance

Actinium: Q3 Earnings Snapshot

NEW YORK (AP) — Actinium Pharmaceuticals Inc. ATNM) on Friday reported a loss of $5.1 million in its third quarter. On a per-share basis, the New York-based company said it had a loss of 16 cents.

vor 10 Monaten · MT Newswires

Sector Update: Health Care Stocks Advance Monday Afternoon

Health care stocks rose Monday afternoon, with the NYSE Health Care Index and the Health Care Select

Seite 1 von 2

Actinium Pharmaceuticals, Inc. (ATNM)